just looking at the SIOI relationship. we had this presented this week
View attachment 6981390View attachment 6981393anteotech has the $1.8m/5 year commercial deal which has already been expanded upon. mainly for vaccine testing. but from above we have diversion of product usage.
we had Merrill state SIOI are looking at lateral flow development. we have papers on our website from SIOI showing anteobind/SIOI relationship in this
View attachment 6981399the components of the assay being nearly the same as a new vaccine SIOI is testing
View attachment 6981492now here is a new bit. I posted this paper from India about extracellular vesicle testing a few weeks ago
78663546and another post
78588507then what could ev be used for
View attachment 6981513what has this to do with SIOI
View attachment 6981525so just to summarise
SIOI are expanding the uses of anteobind. we know with vaccines testing/development (?) , with lateral flow development and maybe with ev tech.
so what is happening
"A visit by SII executives to Brisbane is planned in May 2025"
this is different from anteo visiting them, we are trying to sell them something. why would SII executives visit anteo hq?
could this be a clue
" along with potential monetisation opportunities via strategic or corporate partnerships."
SII have been buying and investing in companies with complimentary tech and do love a photo app at these events.
maybe / maybe not. just something to think about short term !!!! at the minimum, the use of ev's and anteobind shows a huge potential market for anteotech
GLTAH
(20min delay)